These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37298217)

  • 21. Quantification of specific growth patterns and frequency of the empty sella phenomenon in growth hormone-secreting pituitary adenomas.
    Bier G; Hempel JM; Grimm F; Ernemann U; Bender B; Honegger J
    Eur J Radiol; 2018 Jul; 104():79-86. PubMed ID: 29857870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant.
    Ku CR; Lim H; Lee YJ; Kim SH; Kim D; Kim SH; Lee MK; Bang D; Lee EJ
    Sci Rep; 2021 Aug; 11(1):16530. PubMed ID: 34400688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas.
    Ben-Shlomo A; Deng N; Ding E; Yamamoto M; Mamelak A; Chesnokova V; Labadzhyan A; Melmed S
    J Clin Invest; 2020 Nov; 130(11):5738-5755. PubMed ID: 32673291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas.
    Giuffrida G; D'Argenio V; Ferraù F; Lasorsa VA; Polito F; Aliquò F; Ragonese M; Cotta OR; Alessi Y; Oteri R; Di Maggio F; Asmundo A; Romeo PD; Spagnolo F; Pastore L; Angileri FF; Capasso M; Cannavò S; Aguennouz M
    Front Endocrinol (Lausanne); 2022; 13():841118. PubMed ID: 35432200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas.
    Wu Y; Liu C; Yu S; Gao H; Li Z; Li C; Zhang Y
    Oncol Rep; 2016 May; 35(5):2991-9. PubMed ID: 26935389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential biomarkers and lncRNA-mRNA regulatory networks in invasive growth hormone-secreting pituitary adenomas.
    Yin H; Zheng X; Tang X; Zang Z; Li B; He S; Shen R; Yang H; Li S
    J Endocrinol Invest; 2021 Sep; 44(9):1947-1959. PubMed ID: 33559847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas.
    Mayr B; Buslei R; Theodoropoulou M; Stalla GK; Buchfelder M; Schöfl C
    Eur J Endocrinol; 2013 Oct; 169(4):391-400. PubMed ID: 23847328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive expertise in endocrinology: glucose-dependent insulinotropic peptide-dependent Cushing's syndrome.
    Lacroix A
    Eur J Endocrinol; 2023 Mar; 188(3):R56-R72. PubMed ID: 36857084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
    Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzene affects the response to octreotide treatment of growth hormone secreting pituitary adenoma cells.
    Zunino V; Catalano MG; Zenga F; Penner F; Maletta F; Valerio F; Rinella L; Arvat E; Fortunati N
    Environ Res; 2019 Jun; 173():489-496. PubMed ID: 30986651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a rare glucose-dependent insulinotropic polypeptide receptor variant in a patient with diabetes.
    Jacobi SF; Khajavi N; Kleinau G; Teumer A; Scheerer P; Homuth G; Völzke H; Wiegand S; Kühnen P; Krude H; Gong M; Raile K; Biebermann H
    Diabetes Obes Metab; 2019 May; 21(5):1168-1176. PubMed ID: 30784161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake.
    Adriaenssens AE; Biggs EK; Darwish T; Tadross J; Sukthankar T; Girish M; Polex-Wolf J; Lam BY; Zvetkova I; Pan W; Chiarugi D; Yeo GSH; Blouet C; Gribble FM; Reimann F
    Cell Metab; 2019 Nov; 30(5):987-996.e6. PubMed ID: 31447324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells.
    Cuny T; Zeiller C; Bidlingmaier M; Défilles C; Roche C; Blanchard MP; Theodoropoulou M; Graillon T; Pertuit M; Figarella-Branger D; Enjalbert A; Brue T; Barlier A
    Endocr Relat Cancer; 2016 Jul; 23(7):509-19. PubMed ID: 27267119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acromegaly without imaging evidence of pituitary adenoma.
    Lonser RR; Kindzelski BA; Mehta GU; Jane JA; Oldfield EH
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4192-6. PubMed ID: 20610592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPARgamma inhibits GH synthesis and secretion and increases apoptosis of pituitary GH-secreting adenomas.
    Bogazzi F; Ultimieri F; Raggi F; Russo D; Vanacore R; Guida C; Viacava P; Cecchetti D; Acerbi G; Brogioni S; Cosci C; Gasperi M; Bartalena L; Martino E
    Eur J Endocrinol; 2004 Jun; 150(6):863-75. PubMed ID: 15191358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas.
    da Rocha AA; Giorgi RR; de Sa SV; Correa-Giannella ML; Fortes MA; Cavaleiro AM; Machado MC; Cescato VA; Bronstein MD; Giannella-Neto D
    Pituitary; 2006; 9(2):83-92. PubMed ID: 16832584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.
    Ronchi CL; Peverelli E; Herterich S; Weigand I; Mantovani G; Schwarzmayr T; Sbiera S; Allolio B; Honegger J; Appenzeller S; Lania AG; Reincke M; Calebiro D; Spada A; Buchfelder M; Flitsch J; Strom TM; Fassnacht M
    Eur J Endocrinol; 2016 Mar; 174(3):363-72. PubMed ID: 26701869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic rescue of adipocyte glucose-dependent insulinotropic polypeptide receptor expression restores high fat diet-induced body weight gain.
    Ugleholdt R; Pedersen J; Bassi MR; Füchtbauer EM; Jørgensen SM; Kissow HL; Nytofte N; Poulsen SS; Rosenkilde MM; Seino Y; Thams P; Holst PJ; Holst JJ
    J Biol Chem; 2011 Dec; 286(52):44632-45. PubMed ID: 22027838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leptin and the pituitary.
    Sone M; Osamura RY
    Pituitary; 2001; 4(1-2):15-23. PubMed ID: 11824504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel pathway for regulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta cells.
    Lynn FC; Thompson SA; Pospisilik JA; Ehses JA; Hinke SA; Pamir N; McIntosh CH; Pederson RA
    FASEB J; 2003 Jan; 17(1):91-3. PubMed ID: 12475913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.